PVH
67
-2
UHS
60
-3
HST
39
-5
SLB
46
2
OXY
46
2
CAH
43
2
HD
35
-11
CSX
39
-4
AAP
27
3
UPS
51
-2
KIM
51
4
AVGO
57
-4
BMY
35
2
ORCL
68
3
EBAY
43
-2
EXC
58
11
FMC
31
-3
GOOG
75
2
NTAP
72
10
GIS
58
-2
PVH
67
-2
UHS
60
-3
HST
39
-5
SLB
46
2
OXY
46
2
CAH
43
2
HD
35
-11
CSX
39
-4
AAP
27
3
UPS
51
-2
KIM
51
4
AVGO
57
-4
BMY
35
2
ORCL
68
3
EBAY
43
-2
EXC
58
11
FMC
31
-3
GOOG
75
2
NTAP
72
10
GIS
58
-2
Financhill
Back

Replimune Group Stock Predictions

Sell
22

REPL
Replimune Group

Last Price:
6.43
Seasonality Move:
4.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Replimune Group Stock Forecast

  • Over the next 52 weeks, Replimune Group has on average historically risen by 4.3% based on the past 5 years of stock performance.
  • Replimune Group has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Replimune Group Stock Undervalued?
    The current Replimune Group [REPL] share price is $6.44. The Score for REPL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Replimune Group Stock Go Up Next Year?

  • Over the next 52 weeks, Replimune Group has on average historically risen by 4.3% based on the past 5 years of stock performance.

Replimune Group Stock Rating

Sell
22
Replimune Group (REPL) is a Sell

Is Replimune Group overpriced?

  • Replimune Group has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Replimune Group Stock Price History

Is REPL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
replimune.com

52-Week Data

52-Week High:
24.81
52-Week Low:
5.86

Prediction Charts

Market Cap:
395.51M
Price in USD:
6.44
Volume:
901.5K
Beta:
1.53

Technical Analysis

SMA50:
7.30
SMA100:
7.73
SMA200:
11.23
52-Wk Change:
-66.97%

Stock Predictions

  • Is Replimune Group stock public?
    Yes, Replimune Group is a publicly traded company.
  • What is the Replimune Group stock quote today?
    The Replimune Group stock price is 6.44 USD today.
  • How to buy Replimune Group stock online?
    You can buy Replimune Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 6.49 6.35 6.62 6.35
May-1 6.36 6.46 6.76 6.22
May-2 6.54 6.57 6.66 6.37
May-3 6.80 6.95 7.08 6.61
May-6 7.22 7.01 7.24 6.93
May-7 7.04 6.89 7.27 6.83
May-8 6.78 6.68 6.83 6.57
May-9 6.65 6.76 6.79 6.51
May-10 6.76 6.41 6.95 6.38
May-13 6.46 6.59 6.84 6.34
May-14 6.64 6.71 7.01 6.54
May-15 6.92 6.81 6.96 6.72
May-16 6.64 6.72 6.76 6.27
May-17 6.79 6.44 6.93 6.41

Replimune Group Earnings

Replimune Group Earnings Report: Per Share Replimune Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

Replimune Group Forecast Revenue Growth

Replimune Group Stock Analysis: Historical quarterly revenues per share for Replimune Group and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.12 per share.

* Replimune Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.